See today's BioWorld Asia
To read the full story, subscribe or sign in.

Hong Kong PolyU and Macau UST develop recombinant RBD vaccine against COVID-19

Aug. 4, 2020
By Elise Mak
No Comments
Universities in China’s Greater Bay Area have developed a recombinant receptor-binding domain (RBD) protein vaccine candidate that has shown promise against COVID-19, researchers said Monday.
BioWorld Asia Vaccine Asia-Pacific China